Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Proponents often highlight the opportunity for meaningful therapeutic outcomes, particularly in ailments where conventional therapies have proven ineffective. However, crucially important to assess the considerable financial expenditure associated